eMedicine Specialties > Dermatology > Bacterial Infections

Trichomycosis Pubis

Author: Vladimir O Osipov, MD, Assistant Professor, Department of Pathology, Section of Bone and Soft Tissue Pathology, Section of Gastrointestinal Pathology, Medical College of Wisconsin
Coauthor(s): Scott M Acker, MD, Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham; Peter Langenstroer, MD, Associate Professor, Department of Urology, Medical College of Wisconsin; Milton W Datta, MD, Assistant Professor, Departments of Pathology, Urology, and Hematology-Oncology, Emory University School of Medicine
Contributor Information and Disclosures

Updated: Mar 26, 2009

Introduction

Background

Trichomycosis is a bacterial infection of the hair shaft found in sweat gland–bearing areas; it has been described most commonly in the axillary region. While initially believed to be uncommon in the inguinal region, a series of papers have described trichomycosis particular to the inguinal area and have suggested that this disease is underestimated in the general population.

Pathophysiology

This discussion of trichomycosis, a disease specific to the hair and sweat gland–bearing regions of the body, concentrates on the involvement of the pubic region in men (trichomycosis pubis). First described in the axillary region by Paxton in 1869, the causative role of multiple bacterial Corynebacterium species was established by Freeman et al in 1969.1,2,3,4,5 Use of the term trichomycosis, and the implied causative role of fungi, has been maintained. The color differences noted at presentation of the condition, their association with particular corynebacteria, or the possible role of associated cocci have not been clarified.

The causative organism associated with most cases is Corynebacterium tenuis, which prefers the moist microenvironment of the inguinal regions. While as many as 33% of adults have colonization by bacteria in the inguinal or axillary regions, factors such as hyperhidrosis initiate more extensive growth and clinical manifestation. The exact origin of the cement substance that creates the grossly visible nodules is debated. Electron microscopy studies favor origin from the causative agents, while others have favored elaboration from apocrine sweat.6,7 The actual nidus may be through the modification of apocrine sweat by elaborated cement substance to create the insoluble material that holds bacteria to the hair shaft.

Rho et al describe a so-called "corynebacterial triad" that includes erythrasma and trichomycosis axillaris in soldiers with pitted keratolysis.8

Frequency

United States

Detailed examination of racial, age, or geographic incidence has not been performed, and examinations in the United States are limited to case reports. A more detailed examination (but still limited) has been performed outside the United States.

International

Studies in Panama and the United Arab Emirates revealed rates as high as 39% in patients attending a dermatology clinic.9,10 These results correlated with the notably higher incidence in areas of high humidity, warmth, and poor hygiene. The only other study to mention incidence noted the presence of trichomycosis pubis when examining institutionalized mentally retarded patients for trichomycosis axillaris in Edinburgh, Scotland, and noted that of 609 men examined, 16 (2.6%) had pubic disease, of which 3 of the cases (0.5%) were not associated with axillary involvement. Ages of the males affected were 18 and 21 (3 patients) and can be culled only from case reports.

Mortality/Morbidity

Morbidity is low, with most patients unaware of the colonization. When presenting, the most common complaint is a foul odor, and this may continue to cause problems, since trichomycosis often recurs.

Clinical

History

While many patients are asymptomatic, patients have presented because of pubic rash, foul odor, or growths on the pubic hair. Presenting complaints of colored sweat also have been recorded, resulting in a consideration of chromhidrosis.

Physical

Patients typically present with yellow or red nodules on the hair shafts; yellow is most common. Sweat in the region tends to be colored similarly. Lesions present in the inguinal region, often on the scrotum but occasionally on the base of the shaft of the penis. Lesions can be associated with erythema and itching, and superinfection with dermatophytes has been noted.

Causes

Risk factors appear to be geographic, with the highest incidence in tropic areas. In addition, poor hygiene often is present.

Other diagnostic considerations

Clinical separation from other organisms often is not performed, and treatment focuses on the empirical use of drying agents and topical antibiotics. Thus, the use of topical powders can be a confounding factor in diagnosis. True fungal infections (piedra) also may confound the diagnosis but may be present as superinfection. Piedra presents with nodularity of the hair shafts that is either tan to white (white piedra) or black (black piedra), as opposed to the yellow or red nodules of trichomycosis. White piedra may have a gelatinous appearance.

More on Trichomycosis Pubis

Overview: Trichomycosis Pubis
Differential Diagnoses & Workup: Trichomycosis Pubis
Treatment & Medication: Trichomycosis Pubis
Follow-up: Trichomycosis Pubis
References

References

  1. Crissey JT, Rebell GC, Laskas JJ. Studies on the causative organism of trichomycosis axillaris. J Invest Dermatol. May 1952;19(3):187-97. [Medline].

  2. Freeman RG, McBride ME, Knox JM. Pathogenesis of trichomycosis axillaris. Arch Dermatol. Jul 1969;100(1):90-5. [Medline].

  3. McBride ME, Freeman RG, Knox JM. The bacteriology of trichomycosis axillaris. Br J Dermatol. Aug 1968;80(8):509-13. [Medline].

  4. Paxton FV. On a disease condition of the hairs of the axilla, probably of parasitic origin. J Cutan Med. 1869;3:133.

  5. Savin JA, Somerville A, Noble WC. The bacterial flora of trichomycosis axillaris. J Med Microbiol. May 1970;3(2):352-6. [Medline].

  6. Montes L, Vasquez C, Cataldi M. Electron microscopic study of infected hairs in trichomycosis axillaris. J Invest Dermatol. 1963;40:273-8.

  7. White SW, Smith J. Trichomycosis pubis. Arch Dermatol. Apr 1979;115(4):444-5. [Medline].

  8. Rho NK, Kim BJ. A corynebacterial triad: Prevalence of erythrasma and trichomycosis axillaris in soldiers with pitted keratolysis. J Am Acad Dermatol. Feb 2008;58(2 Suppl):S57-8. [Medline].

  9. Lestringant GG, Qayed KI, Fletcher S. Is the incidence of trichomycosis of genital hair underestimated?. J Am Acad Dermatol. Feb 1991;24(2 Pt 1):297-8. [Medline].

  10. Zaias N, Taplin D, Rebell GS. Final Report, Republic of Panama Medical Research. Washington, DC: Walter Reed Army Institute of Research; 1964.

  11. Bargman H. Trichomycosis of the scrotal hair. Arch Dermatol. Mar 1984;120(3):299. [Medline].

  12. Noble WC, Savin JA. Trichomycosis of the scrotal hair. Arch Dermatol. Jan 1985;121(1):25. [Medline].

  13. Rosen T, Krawczynska AM, McBride ME, Ellner K. Naftifine treatment of trichomycosis pubis. Int J Dermatol. Sep 1991;30(9):667-9. [Medline].

  14. O'Dell ML. Skin and wound infections: an overview. Am Fam Physician. May 15 1998;57(10):2424-32. [Medline][Full Text].

Further Reading

Keywords

trichomycosis pubis, trichomycosis, bacterial infection, hair shaft infection

Contributor Information and Disclosures

Author

Vladimir O Osipov, MD, Assistant Professor, Department of Pathology, Section of Bone and Soft Tissue Pathology, Section of Gastrointestinal Pathology, Medical College of Wisconsin
Vladimir O Osipov, MD is a member of the following medical societies: American Society for Clinical Pathology, College of American Pathologists, and United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.

Coauthor(s)

Scott M Acker, MD, Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham
Scott M Acker, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society for Clinical Pathology, and Southern Medical Association
Disclosure: Nothing to disclose.

Peter Langenstroer, MD, Associate Professor, Department of Urology, Medical College of Wisconsin
Peter Langenstroer, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Milton W Datta, MD, Assistant Professor, Departments of Pathology, Urology, and Hematology-Oncology, Emory University School of Medicine
Milton W Datta, MD is a member of the following medical societies: College of American Pathologists and United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.

Medical Editor

Daniel Mark Siegel, MD, MS, Director, Procedural Dermatology Fellowship Program, Clinical Professor of Dermatology, Department of Dermatology, State University of New York Downstate
Daniel Mark Siegel, MD, MS is a member of the following medical societies: American Academy of Dermatology, American Academy of Facial Plastic and Reconstructive Surgery, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American College of Physician Executives, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, American Society for MOHS Surgery, and International Society for Dermatologic Surgery
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory
Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.